IgG4相关眼病的治疗结局及其决定因素:一项全地区队列研究
该回顾性队列纳入101例活检证实的中国IgG4相关眼病患者,至少随访24个月。82%以口服糖皮质激素为一线治疗,其中61%需长期维持激素。基线血清IgG4升高和Mikulicz综合征与激素依赖相关。减容手术可能是离散眶内病变、基线IgG4正常且无Mikulicz综合征患者的替代选择。
要点
- 82%(82/101)患者以口服糖皮质激素为一线治疗,61%(50/82)需长期维持激素。
- 激素依赖与基线血清IgG4升高(94% vs 65%,p<0.01)和Mikulicz综合征(46% vs 18%,p<0.05)相关。
- 17%(17/101)患者活检后无需任何药物治疗,多具有减容手术史、离散眶内病变、基线IgG4正常且无Mikulicz综合征。
核心结论
- 本队列中60%患者需长期口服糖皮质激素维持治疗。
- 治疗前血清IgG4升高和Mikulicz综合征与激素依赖相关。
- 减容手术是离散眶内病变、基线IgG4正常且无Mikulicz综合征亚组患者的替代选择。
研究设计与样本
- 回顾性、设盲的医学记录、眶部影像和组织病理报告审查。
- 全城市范围、活检证实的中国队列,101例患者至少随访24个月。
主要发现
- 82%(82/101)患者以口服糖皮质激素为一线治疗,其中7例同时接受激素节约剂(SSA)/生物制剂作为主要治疗。
- 61%(50/82)患者在1.9±0.7次(范围1-5)复发后需长期糖皮质激素(单用=23,联合SSA=27)。
- 与21%(17/82)成功在24个月内逐渐减停激素的患者相比,激素依赖与基线血清IgG4升高(94% vs 65%,p<0.01)和Mikulicz综合征(46% vs 18%,p<0.05)相关。
- 13%(11/82)患者在减停激素后耐受残留病变。
- 17%(17/101)患者活检后无需任何药物治疗,他们更可能有减容手术(71% vs 40%,p<0.05)、离散眶内病变(65% vs 26%,p<0.05)、基线血清IgG4正常(24% vs 6%,p<0.05)和无Mikulicz综合征(94% vs 61%,p<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Oral corticosteroid remains the first-line treatment of IgG4-related ophthalmic disease, but steroid-dependence is common and serious. Factors associated with steroid dependence and relapse have to be further explored. STUDY POPULATION: A city-wide, biopsy-proven, Chinese cohort. METHODS: Retrospective, masked review of medical records, orbital images and histopathology reports. RESULTS: There were 101 patients with at least 24-month follow-up. Up to 82% (82/101) received oral corticosteroid as first-line treatments, and 7 of them received also concomitant steroid-sparing agents (SSA)/biological agents as primary treatment. There was 61% (50/82) of patients required long-term corticosteroid (alone=23, with SSA=27) after 1.9±0.7 (range 1-5) relapses. When compared with the 21% (17/82) of patients who tapered corticosteroid successfully for 24 months, steroid dependence was associated with elevated baseline serum IgG4 level (94% vs 65%, p<0.01) and Mikulicz syndrome (46% vs 18%, p<0.05). Up to 13% (11/82) of patients tolerated residual disease after tapering off corticosteroid. There was 17% (17/101) of patients did not require any medications after biopsies. They were more likely to have debulking surgeries (71% vs 40%, p<0.05), discrete orbital lesions (65% vs 26%, p<0.05), normal baseline serum IgG4 level (24% vs 6%, p<0.05) and no Mikulicz syndrome (94% vs 61%, p<0.05). CONCLUSION: In this cohort, 60% of patients required long-term maintenance oral corticosteroid. Elevated pretreatment serum IgG4 level and Mikulicz syndrome were associated with steroid dependence. Debulking surgery is an alternative for a subgroup of patients with discrete orbital lesions, normal baseline IgG4 level and no Mikulicz syndrome.
引用
- Lai KKH, Li EYM, Chan RYC, et al. Treatment outcomes and their determinants of IgG4-related ophthalmic disease: a territory-wide cohort study. Br J Ophthalmol. 2023. PMID: 36288914. doi:10.1136/bjo-2021-320936
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。